Last Updated: September 25, 2026

Details for Patent: 10,624,855


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,624,855 protect, and when does it expire?

Patent 10,624,855 protects VELPHORO and is included in one NDA.

Protection for VELPHORO has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has forty-one patent family members in nineteen countries.

Summary for Patent: 10,624,855
Title:Pharmaceutical composition, comprising phosphate binder particles
Abstract:The present invention relates to pharmaceutical composition, comprising certain phosphate binder particles having a certain particle size distribution, a process for the manufacture of the pharmaceutical composition and the use of sucroferric oxyhydroxide having a certain particle size distribution for the manufacture of a pharmaceutical composition.
Inventor(s):Laurent Chofflon, Erik Philipp
Assignee: Vifor Fresenius Medical Care Renal Pharma Ltd
Application Number:US15/039,633
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 10,624,855
Patent Claim Types:
see list of patent claims
Composition; Dosage form;

Drugs Protected by US Patent 10,624,855

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Vifor Fresenius VELPHORO ferric oxyhydroxide TABLET, CHEWABLE;ORAL 205109-001 Nov 27, 2013 RX Yes Yes ⤷  Start Trial ⤷  Start Trial Y ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 10,624,855

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
13194632Nov 27, 2013
14156793Feb 26, 2014
PCT Information
PCT FiledNovember 26, 2014PCT Application Number:PCT/EP2014/075640
PCT Publication Date:June 04, 2015PCT Publication Number: WO2015/078900

International Family Members for US Patent 10,624,855

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2014356500 ⤷  Start Trial
Australia 2020217386 ⤷  Start Trial
Australia 2022204380 ⤷  Start Trial
Canada 2931173 ⤷  Start Trial
China 105764492 ⤷  Start Trial
Cyprus 1123956 ⤷  Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.